Geneos Wealth Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
Geneos Wealth Management's NEO Position: Q1 2026 in Review
Geneos Wealth Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 50 shares — an estimated $588 sold.
Geneos Wealth Management first reported a position in NEO in Q1 2016 and held it in 21 quarters. The position peaked at $29K in Q4 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Geneos Wealth Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Geneos Wealth Management sold 50 NeoGenomics shares in Q1 2026, an estimated $588.
- Geneos Wealth Management first reported a position in NeoGenomics in Q1 2016 and held it in 21 quarters.
- Geneos Wealth Management's NeoGenomics position peaked at $29K in Q4 2019.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.